Positioned to Unlock M&A Value through U.S. Manufacturing Amidst Geopolitical Complexities and Specialty Portfolio ...

Global market forecasts project a dramatic shift from today's recreational-dominated market to a trillion-dollar pharmaceutical-centric future within ...

Indian CDMOs are strategically expanding through acquisitions in the US and Europe, driven by global pharma's nearshoring ...

Pharmaceutical construction projects often involve numerous stakeholders ... By identifying potential issues in the design phase, companies can avoid costly errors and ensure smoother project ...

GenScript, a global leader in life science research tools and services support, has expanded its mRNA synthesis and ...

STOCKHOLM, SE / ACCESS Newswire / June 4, 2025 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) - AlzeCure Pharma AB (publ) (FN STO: ALZCUR), a pharmaceutical company that develops candidate drugs for diseases ...

As geopolitical tensions prompt global pharmaceutical giants to pivot away from China, India's Contract Development and ...

R&D spending across the global pharmaceutical sector climbed 1.5% in 2024, according to unreleased data from Evaluate Pharma.

STOCKHOLM, SE / ACCESS Newswire / June 3, 2025 / AlzeCure Pharma AB (publ) (FN STO:ALZCUR), a pharmaceutical company that develops candidate drugs for diseases affecting the nervous system, focusing ...

This online-only abstract outlines a Project Optimus-aligned approach to define the optimal therapeutic window of PCS11T, a tumor-targeted pro-drug of SN-38. PCS11T is designed to increase drug ...

Jefferies has predicted more small tuck-in deals to come, as biotechs struggle to access capital despite key clinical ...

Pharma Equity Group A/S Launches New Strategy to Drive Growth and Shareholder Returns 28 May 2025Announcement no. 7 Pharma Equity Group (PEG) today announces the launch of a transformative investment ...